Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajic.2013.03.297 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders.
Nat Rev Clin Oncol
May 2024
Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Stratification of Risk Factors of Lung Cancer-Associated Venous Thromboembolism and Determining the Critical Point for Preemptive Intervention: A Systematic Review With Meta-analysis.
Clin Med Insights Oncol
June 2023
Department of Physiotherapy, Evangel University, Akaeze, Nigeria.
Background: Several biomarkers or risk factors have been identified and several prediction models exist. The major limitations inherent in these models include cost-ineffectiveness and lack of systematic stratification of risk factors resulting in the inclusion of clinically insignificant biomarkers in the models. This review aimed to systematically stratify the risk factors of lung cancer-associated venous thromboembolism (VTE) and determine the critical point for preemptive intervention.
View Article and Find Full Text PDFAminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large-scale screening.
Pediatr Pulmonol
March 2023
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Background: MT-RNR1 variants are a well-known cause of aminoglycoside-induced hearing loss (AIHL). Individuals with cystic fibrosis (CF) routinely receive aminoglycosides and are at high risk of AIHL. However, genetic testing before treatment is not routinely performed due to perceived rarity of risk, and cost ineffectiveness with traditional technologies.
View Article and Find Full Text PDFBackground: The use of point-of-care testing (POCT) in different clinical applications is justified by the fact that the time to release the result is shortened, allowing the physician to define the diagnosis and most appropriate therapy in a shorter time. However, the negative aspects must also be highlighted and studied so that we can move forward with the use of these devices. These negative aspects include greater analytical imprecision compared to laboratory automation, the variability between different equipment from different manufacturers, the risk of inappropriate use, a low level of global regulation, higher costs compared with laboratory testing and cost ineffectiveness in terms of health care.
View Article and Find Full Text PDFClinical- and cost-ineffectiveness of targeted methicillin-resistant Staphylococcus aureus screening of high-risk patients admitted to a low-prevalence teaching hospital.
Am J Infect Control
November 2013
Clinical Microbiology Laboratory, Infection Control Section, and Infectious Disease Division, Winthrop-University Hospital, Mineola, NY; School of Medicine, State University of New York, Stony Brook, NY. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!